This study looks at how two ways of checking blood sugar, Dexcom G7 Continuous Glucose Monitoring (CGM) and Point of Care (POC) Blood Glucose Testing, work for people with Type 1 Diabetes (T1D) in the hospital. T1D is when the body doesn't make insulin, a hormone that helps sugar enter cells for energy. Many T1D patients face issues like hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar) during their hospital stay. The study will see if CGM, which continuously checks blood sugar, is better at keeping it at safer levels compared to POC, which is checked less frequently. The study will help doctors decide the best way to manage blood sugar in the hospital.
- Duration: Participants need to stay in the hospital for more than 3 days.
- Eligibility: Must have T1D and not be using CGM before admission.
- Risks: No extra risk from CGM, but participants must wear the device.
How understandable was the trial content above?
Hard to understand
Easy to understand